Detalhe da pesquisa
1.
Brachytherapy: An overview for clinicians.
CA Cancer J Clin
; 69(5): 386-401, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361333
2.
Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection.
Int J Gynecol Cancer
; 34(5): 730-737, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485223
3.
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid.
Mol Cancer
; 22(1): 178, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932736
4.
Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Gynecol Oncol
; 168: 32-38, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370612
5.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
6.
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
Ann Surg Oncol
; 29(2): 1165-1170, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596794
7.
Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
Ann Surg Oncol
; 29(9): 5894-5903, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590116
8.
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.
Gynecol Oncol
; 167(1): 11-21, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970603
9.
Combined modality including novel sensitizers in gynecological cancers.
Int J Gynecol Cancer
; 32(3): 389-401, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35256428
10.
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.
Cancer Immunol Immunother
; 70(2): 519-531, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852603
11.
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ann Surg Oncol
; 28(11): 6714-6720, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768396
12.
Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian Tumors.
Ann Surg Oncol
; 28(7): 3597-3604, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140251
13.
False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
BMC Cancer
; 21(1): 135, 2021 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549033
14.
Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.
Gynecol Oncol
; 160(1): 279-284, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162175
15.
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.
Gynecol Oncol
; 160(1): 77-82, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059915
16.
Cancer surgery during the COVID-19 pandemic: The experience of a comprehensive cancer center performing preoperative screening by RT-PCR and chest CT scan.
J Surg Oncol
; 123(4): 815-822, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524172
17.
Feasibility of a video-based cognitive behavioral therapy for insomnia in French adult cancer outpatients: results from the Sleep-4-All-1 study.
Support Care Cancer
; 29(10): 5883-5894, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761001
18.
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours.
Br J Cancer
; 122(4): 564-568, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844183
19.
Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors.
Gynecol Oncol
; 158(3): 659-665, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571680
20.
A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.
Gynecol Oncol
; 159(2): 534-538, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32828580